Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iván Parra-Izquierdo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Frontiers in Physiology|March 30, 2018
Toll-Like Receptors, Inflammation, and Calcific Aortic Valve DiseaseCarmen García-Rodríguez, Iván Parra-Izquierdo, Irene Castaños-Mollor, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 21, 2018
Calcification Induced by Type I Interferon in Human Aortic Valve Interstitial Cells Is Larger in Males and Blunted by a Janus Kinase InhibitorIván Parra-Izquierdo, Irene Castaños-Mollor, Javier López, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 30, 2019
Lipopolysaccharide and interferon-γ team up to activate HIF-1α via STAT1 in normoxia and exhibit sex differences in human aortic valve interstitial cellsIván Parra-Izquierdo, Irene Castaños-Mollor, Javier López, et al.
The FEBS Journal|May 19, 2021
Clinically used JAK inhibitor blunts dsRNA-induced inflammation and calcification in aortic valve interstitial cellsIván Parra-Izquierdo, Tania Sánchez-Bayuela, Irene Castaños-Mollor, et al.
American Journal of Physiology. Cell Physiology|August 8, 2022
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiologyTony J Zheng, Iván Parra-Izquierdo, Stéphanie E Reitsma, et al.
International Journal of Molecular Sciences|October 13, 2021
Interferons Are Pro-Inflammatory Cytokines in Sheared-Stressed Human Aortic Valve Endothelial CellsIván Parra-Izquierdo, Tania Sánchez-Bayuela, Javier López, et al.
Frontiers in Immunology|September 16, 2021
The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell InteractionsIván Parra-Izquierdo, Hari Hara Sudhan Lakshmanan, Alexander R Melrose, et al.
Platelets|June 7, 2021
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet functionIván Parra-Izquierdo, Alexander R Melrose, Jiaqing Pang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 2025
Inflammation via JAK-STAT/HIF-1α Drives Metabolic Changes in Pentose Phosphate Pathway and Glycolysis That Support Aortic Valve Cell CalcificationTania Sánchez-Bayuela, Mirian Peral-Rodrigo, Iván Parra-Izquierdo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet functionYiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Frontiers in Physiology|March 30, 2018
Toll-Like Receptors, Inflammation, and Calcific Aortic Valve DiseaseCarmen García-Rodríguez, Iván Parra-Izquierdo, Irene Castaños-Mollor, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 21, 2018
Calcification Induced by Type I Interferon in Human Aortic Valve Interstitial Cells Is Larger in Males and Blunted by a Janus Kinase InhibitorIván Parra-Izquierdo, Irene Castaños-Mollor, Javier López, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 30, 2019
Lipopolysaccharide and interferon-γ team up to activate HIF-1α via STAT1 in normoxia and exhibit sex differences in human aortic valve interstitial cellsIván Parra-Izquierdo, Irene Castaños-Mollor, Javier López, et al.
The FEBS Journal|May 19, 2021
Clinically used JAK inhibitor blunts dsRNA-induced inflammation and calcification in aortic valve interstitial cellsIván Parra-Izquierdo, Tania Sánchez-Bayuela, Irene Castaños-Mollor, et al.
American Journal of Physiology. Cell Physiology|August 8, 2022
Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiologyTony J Zheng, Iván Parra-Izquierdo, Stéphanie E Reitsma, et al.
International Journal of Molecular Sciences|October 13, 2021
Interferons Are Pro-Inflammatory Cytokines in Sheared-Stressed Human Aortic Valve Endothelial CellsIván Parra-Izquierdo, Tania Sánchez-Bayuela, Javier López, et al.
Frontiers in Immunology|September 16, 2021
The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell InteractionsIván Parra-Izquierdo, Hari Hara Sudhan Lakshmanan, Alexander R Melrose, et al.
Platelets|June 7, 2021
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet functionIván Parra-Izquierdo, Alexander R Melrose, Jiaqing Pang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 2025
Inflammation via JAK-STAT/HIF-1α Drives Metabolic Changes in Pentose Phosphate Pathway and Glycolysis That Support Aortic Valve Cell CalcificationTania Sánchez-Bayuela, Mirian Peral-Rodrigo, Iván Parra-Izquierdo, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet functionYiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Pageof 2